@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix go: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix hasAgent: . @prefix RNA: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0042789 . sub:_2 geneProductOf: hgnc:11209; a Protein: . sub:_3 geneProductOf: hgnc:801; a RNA: . sub:_4 occursIn: species:9606; rdf:object sub:_3; rdf:predicate belv:directlyIncreases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "tscript(p(HGNC:SP4)) => r(HGNC:ATP1A3)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "1.4" . sub:_5 prov:value "EMSA and supershift experiments with specific antibodies allowed us to demonstrate that both the Sp1 I and Sp1 II sites can bind Sp1, Sp3 and Sp4, and that the putative CAAT box is actually recognized by the transcription factor NF-Y. In contrast, DNA-protein interaction studies ruled out that the half-CRE site could actually bind some members of the CREB transcription factor family, and showed that additional nucleotides at the 5? end of this site are needed for the binding of an unknown factor."; prov:wasQuotedFrom pubmed:15462673 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:15462673; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:28.299+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }